vimarsana.com
Home
Live Updates
Without RCT FDA May Consider Estrogen Approval For Gender Incongruence : vimarsana.com
Without RCT FDA May Consider Estrogen Approval For Gender Incongruence : vimarsana.com
Without RCT FDA May Consider Estrogen Approval For Gender Incongruence
The FDA may consider approval of the cross-sex hormone estradiol for gender incongruence in adults and minors based on an observational study and not an RCT with placebo.
Related Keywords
United Kingdom ,
Denmark ,
France ,
Sweden ,
Netherlands ,
Norway ,
Finland ,
British ,
David Sackett ,
Research Institute For Gender Therapeutics ,
Drug Administration ,
Research Institute ,
New England Journal ,
Western European ,
British Medical Journal ,
Gender Incongruence ,
Minors ,
Puberty Blockers ,
Cross Sex Hormones ,
Fda ,
Estradiol ,
Estrogen ,
Rct ,
Observational Study ,
Gender Affirming Care ,